The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Is The Forecasted Market Value Of The Inactivated Vaccines Market Across 2026–2030?
The inactivated vaccines market size has seen consistent expansion in recent years. It is projected to increase from $6.37 billion in 2025 to $6.61 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 3.9%. This historical growth can be ascribed to the escalating occurrence of infectious diseases, developments in virology research, governmental financial support for immunization, the broadening of healthcare infrastructure, and public information campaigns for vaccination.
The inactivated vaccines market is projected to experience substantial expansion in the coming years, with its valuation set to reach $8.07 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 5.1%. This anticipated growth is primarily driven by factors such as an expanding elderly demographic, enhanced healthcare accessibility within emerging markets, innovations in vaccine delivery mechanisms, a surge in worldwide immunization efforts, and the increasing uptake of multi-dose and combination vaccines. Key developments expected during this period involve progress in vaccine formulation, the broadening of cold chain logistics, a rising need for pediatric vaccines, an increase in governmental immunization schemes, and the ongoing creation of combination vaccines.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13018&type=smp
What Drivers Are Shaping The Future Growth Of The Inactivated Vaccines Market?
The increasing prevalence of infectious diseases is projected to drive the growth of the inactivated vaccine market moving forward. Infectious diseases are conditions caused by pathogens such as bacteria, viruses, fungi, or parasites that can spread between individuals, resulting in diverse symptoms and health complications, with tuberculosis being one such example. Inactivated vaccines work by employing non-living pathogens to stimulate an immune response, effectively preventing diseases like polio, hepatitis A, and influenza. For instance, in November 2023, data from an article published by the Centers for Disease Control and Prevention, a US-based national public health agency, revealed that the number of tuberculosis patients in the USA escalated from 8,320 in 2022 to 9,615 in 2023, signifying an increase of 1,295 cases. Consequently, the rising occurrence of infectious diseases is fueling the expansion of the inactivated vaccine market.
What Segmentation Levels Are Considered In The Inactivated Vaccines Market?
The inactivated vaccines market covered in this report is segmented –
1) By Type: Viral Vaccine, Bacterial Vaccine
2) By Method Of Inactivation: Solvent Detergent, Radiation, pH Concentration, Heat Inactivation, Other Methods Of Inactivation
3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Other Distribution Channels
Subsegments:
1) By Viral Vaccine: Inactivated Poliovirus Vaccine (IPV), Inactivated Influenza Vaccine, Inactivated Hepatitis A Vaccine, Inactivated Rabies Vaccine
2) By Bacterial Vaccine: Inactivated Typhoid Vaccine, Inactivated Cholera Vaccine, Inactivated Pertussis Vaccine, Inactivated Plague Vaccine
What Trends Are Projected To Affect The Inactivated Vaccines Market?
Major companies operating in the inactivated vaccines market are focusing on increasing product launches and securing regulatory approvals to enhance their global vaccine portfolios and address growing immunization needs. For instance, in April 2024, Sanofi S.A., a France-based healthcare company, introduced Verorab, its inactivated rabies vaccine, in the UK for use across all age groups in both pre-exposure and post-exposure situations. This launch highlights the company’s ongoing dedication to expanding its range of inactivated vaccines and strengthening its global immunization offerings. The move also reflects increasing investments and rising regulatory momentum surrounding inactivated vaccine development and approvals. As more companies advance similar products and broaden their portfolios, these strategic initiatives are collectively driving significant growth in the inactivated vaccines market, supporting wider protection against infectious diseases.
Which Leading Firms Are Contributing To The Growth Of The Inactivated Vaccines Market?
Major companies operating in the inactivated vaccines market are Pfizer Inc., Sinopharm Group Co. Ltd., Merck & Co. Inc., Sanofi S.A., GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, CSL Limited, Daiichi Sankyo Company Limited, Zydus Lifesciences Ltd., Sinovac Biotech Ltd., Biological E Limited, Hualan Biological Engineering Inc., Shenzhen Kangtai Biological Products Co. Ltd., Serum Institute of India Pvt. Ltd., Beijing Tiatan Biological Products Co. Ltd., Valneva SE, Beijing Minhai Biotechnology Co. Ltd., Bharat Biotech International Limited, Panacea Biotec Ltd., Sinergium Biotech SA, Bharat Immunologicals and Biologicals Corporation Limited, Haffkine Biopharmaceutical Corporation Limited, Incepta Vaccine Ltd., Changchun BCHT Biotechnology Co. Ltd.
Read the full inactivated vaccines market report here:
https://www.thebusinessresearchcompany.com/report/inactivated-vaccines-global-market-report
Which Geographic Regions Are Influencing Demand In The Inactivated Vaccines Market?
North America was the largest region in the inactivated vaccines market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the inactivated vaccines market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Inactivated Vaccines Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=13018&type=smp
Browse Through More Reports Similar to the Global Inactivated Vaccines Market 2026, By The Business Research Company
Inactivated Vaccines Market Report 2026
https://www.thebusinessresearchcompany.com/report/inactivated-vaccines-global-market-report
Vaccines Market Report 2026
https://www.thebusinessresearchcompany.com/report/vaccines-global-market-report
Therapeutic Bcg Vaccines Market Report 2026
https://www.thebusinessresearchcompany.com/report/therapeutic-bcg-vaccines-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model